PTEN gene: A model for genetic diseases in dermatology

The Scientific World Journal

Volumn 2012, Issue , 2012, Pages

  Romano, Corrado ^a   Schepis, Carmelo ^a  

^a OASI RESEARCH INSTITUTE IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; TRANSFORMING GROWTH FACTOR BETA; PTEN PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

BREAST CANCER; CANCER THERAPY; CELL INTERACTION; COWDEN SYNDROME; DERMATOLOGIST; EPIGENETICS; EXTRACELLULAR MATRIX; GENE MUTATION; GENE SILENCING; GENETIC DISORDER; GLIOBLASTOMA; HAMARTOMA; HETEROZYGOSITY LOSS; HUMAN; LHERMITTE DUCLOS DISEASE; MELANOMA; MULTIPLE CANCER; NONHUMAN; PROSTATE CANCER; PROTEIN LOCALIZATION; PROTEIN PROCESSING; REVIEW; SKIN CARCINOGENESIS; SKIN DISEASE; ARTICLE; CONGENITAL TUMOR; GENETICS; SKIN TUMOR; TUMOR SUPPRESSOR GENE;

GENES, TUMOR SUPPRESSOR; HAMARTOMA SYNDROME, MULTIPLE; HUMANS; MELANOMA; PROTEUS SYNDROME; PTEN PHOSPHOHYDROLASE; SKIN NEOPLASMS; TUMOR SUPPRESSOR PROTEINS;

EID: 84861028929     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/2012/252457     Document Type: Review

References (89)

1. Salmena L., Carracedo A., Pandolfi P. P., Tenets of PTEN tumor suppression Cell 2008 133 3 403 414 (Pubitemid 351622014)
2. Li J., Yen C., Liaw D., Podsypanina K., Bose S., Wang S. I., Puc J., Miliaresis C., Rodgers L., McCombie R., Bigner S. H., Giovanella B. C., Ittmann M., Tycko B., Hibshoosh H., Wigler M. H., Parsons R., PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer Science 1997 275 5308 1943 1947 (Pubitemid 27148818)
3. Steck P. A., Pershouse M. A., Jasser S. A., Yung W. K. A., Lin H., Ligon A. H., Langford L. A., Baumgard M. L., Hattier T., Davis T., Frye C., Hu R., Swedlund B., Teng D. H. F., Tavtigian S. V., Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers Nature Genetics 1997 15 4 356 362 (Pubitemid 27147102)
4. Knudson A. G., Mutation and cancer: statistical study of retinoblastoma Proceedings of the National Academy of Sciences of the United States of America 1971 68 4 820 823
5. Liaw D., Marsh D. J., Li J., Dahia P. L. M., Wang S. I., Zheng Z., Bose S., Call K. M., Tsou H. C., Peacocke M., Eng C., Parsons R., Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome Nature Genetics 1997 16 1 64 67 (Pubitemid 27198157)
6. Weary P. E., Gorlin R. J., Gentry W. C., Comer J. E., Greer K. E., Multiple hamartoma syndrome (Cowden's disease) Archives of Dermatology 1972 106 5 682 690
7. Chen J., Lindblom P., Lindblom A., A study of the PTEN/MMAC1 gene in 136 breast cancer families Human Genetics 1998 102 1 124 125
8. Saal L. H., Gruvberger-Saal S. K., Persson C., Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair Nature Genetics 2008 40 1 102 107
9. Marsh D. J., Kum J. B., Lunetta K. L., Bennett M. J., Gorlin R. J., Ahmed S. F., Bodurtha J., Crowe C., Curtis M. A., Dasouki M., Dunn T., Feit H., Geraghty M. T., Graham J. M., Hodgson S. V., Hunter A., Korf B. R., Manchester D., Miesfeldt S., Murday V. A., Nathanson K. L., Parisi M., Pober B., Romano C., Tolmie J. L., Trembath R., Winter R. M., Zackai E. H., Zori R. T., Weng L. P., Dahia P. L. M., Eng C., PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome Human Molecular Genetics 1999 8 8 1461 1472 (Pubitemid 29374079)
10. Cohen M. M. Jr., Bannayan-Riley-Ruvalcaba Syndrome: renaming three formerly recognized syndromes as one etiologic entity American Journal of Medical Genetics 1990 35 2 291 2292
11. Wiedemann H. R., Burgio G. R., Aldenhoff P., Kunze J., Kaufmann H. J., Schirg E., The proteus syndrome. Partial gigantism of the hands and/or feet, nevi, hemihypertrophy, subcutaneous tumors, microcephaly and other skull anomalies and possible accelerated growth and visceral affections European Journal of Pediatrics 1983 140 5 12 (Pubitemid 13121993)
12. Zhou X. P., Marsh D. J., Hampel H., Mulliken J. B., Gimm O., Eng C., Germline and germline mosaic PTEN mutations associated with a Proteus-like syndrome of hemihypertrophy, lower limb asymmetry, arteriovenous malformations and lipomatosis Human Molecular Genetics 2000 9 5 765 768 (Pubitemid 30162760)
13. Dastur H. M., Pandya S. K., Deshpande D. H., Diffuse cerebellar hypertrophy. (Lhermitte Duclos disease) Neurology India 1975 23 1 53 56
14. Myers M. P., Stolarov J. P., Eng C., Li J., Wang S. I., Wigler M. H., Parsons R., Tonks N. K., P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase Proceedings of the National Academy of Sciences of the United States of America 1997 94 17 9052 9057
15. Li D. M., Sun H., PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells Proceedings of the National Academy of Sciences of the United States of America 1998 95 26 15406 15411 (Pubitemid 29018711)
16. Denu J. M., Stuckey J. A., Saper M. A., Dixon J. E., Form and function in protein dephosphorylation Cell 1996 87 3 361 364 (Pubitemid 26374310)
17. Myers M. P., Tonks N. K., PTEN: sometimes taking it off can be better than putting it on American Journal of Human Genetics 1997 61 6 1234 1238 (Pubitemid 28046897)
18. Zundel W., Schindler C., Haas-Kogan D., Koong A., Kaper F., Chen E., Gottschalk A. R., Ryan H. E., Johnson R. S., Jefferson A. B., Stokoe D., Giaccia A. J., Loss of PTEN facilitates HIF-1-mediated gene expression Genes and Development 2000 14 4 391 396 (Pubitemid 30131884)
19. Dahia P. L. M., Aguiar R. C. T., Alberta J., Kum J. B., Caron S., Sill H., Marsh D. J., Ritz J., Freedman A., Stiles C., Eng C., PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanisms in haematological malignancies Human Molecular Genetics 1999 8 2 185 193 (Pubitemid 29054260)
20. Tamura M., Gu J., Matsumoto K., Aota S. I., Parsons R., Yamada K. M., Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN Science 1998 280 5369 1614 1617 (Pubitemid 28277707)
21. Di Cristofano A., Pesce B., Cordon-Cardo C., Pandolfi P. P., Pten is essential for embryonic development and tumour suppression Nature Genetics 1998 19 4 348 355 (Pubitemid 28357906)
22. Suzuki A., de La Pompa J. L., Stambolic V., Elia A. J., Sasaki T., Del Barco Barrantes I., Ho A., Wakeham A., Itie A., Khoo W., Fukumoto M., Mak T. W., High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice Current Biology 1998 8 21 1169 1178 (Pubitemid 28494715)
23. Podsypanina K., Ellenson L. H., Nemes A., Gu J., Tamura M., Yamada K. M., Cordon-Cardo C., Catoretti G., Fisher P. E., Parsons R., Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems Proceedings of the National Academy of Sciences of the United States of America 1999 96 4 1563 1568 (Pubitemid 29098491)
24. Weng L. P., Smith W. M., Brown J. L., Eng C., PTEN inhibits insulin-stimulated MEK/MAPK activation and cell growth by blocking IRS-1 phosphorylation and IRS-1/Grb-2/Sos complex formation in a breast cancer model Human Molecular Genetics 2001 10 6 605 616 (Pubitemid 32229365)
25. Weng L. P., Brown J. L., Baker K. M., Ostrowski M. C., Eng C., PTEN blocks insulin-mediated ETS-2 phosphorylation through MAP kinase, independently of the phosphoinositide 3-kinase pathway Human Molecular Genetics 2002 11 15 1687 1696 (Pubitemid 34812090)
26. Newton H. B., Molecular neuro-oncology and development of targeted therapeutic strategies for brain tumors. Part 2: PI3K/Akt/PTEN, mTOR, SHH/PTCH and angiogenesis Expert Review of Anticancer Therapy 2004 4 1 105 128 (Pubitemid 38208491)
27. Vivanco I., Sawyers C. L., The phosphatidylinositol 3-kinase-AKT pathway in human cancer Nature Reviews Cancer 2002 2 7 489 501 (Pubitemid 37328931)
28. Martin K. A., Blenis J., Coordinate regulation of translation by the PI 3-kinase and mTOR pathways Advances in Cancer Research 2002 86 1 39
29. Wymann M. P., Pirola L., Structure and function of phosphoinositide 3-kinases Biochimica et Biophysica Acta 1998 1436 1-2 127 150
30. Rameh L. E., Cantley L. C., The role of phosphoinositide 3-kinase lipid products in cell function The Journal of Biological Chemistry 1999 274 13 8347 8350 (Pubitemid 29164617)
31. Di Cristofano A., Kotsi P., Peng Y. F., Cordon-Cardo C., Elkon K. B., Pandolfi P. P., Impaired Fas response and autoimmunity in Pten(+/-) mice Science 1999 285 5436 2122 2125 (Pubitemid 29451429)
32. Di Cristofano A., De Acetis M., Koff A., Cordon-Cardo C., P Pandolfi P., Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse Nature Genetics 2001 27 2 222 224 (Pubitemid 32157454)
33. Dahia P. L. M., PTEN, a unique tumor suppressor gene Endocrine-Related Cancer 2000 7 2 115 129 (Pubitemid 30609989)
34. Gray I. C., Stewart L. M. D., Phillips S. M. A., Hamilton J. A., Gray N. E., Watson G. J., Spurr N. K., Snary D., Mutation and expression analysis of the putative prostate tumour-suppressor gene PTEN British Journal of Cancer 1998 78 10 1296 1300 (Pubitemid 28495240)
35. Whang Y. E., Wu X., Suzuki H., Reiter R. E., Tran C., Vessella R. L., Said J. W., Isaacs W. B., Sawyers C. L., Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression Proceedings of the National Academy of Sciences of the United States of America 1998 95 9 5246 5250 (Pubitemid 28208583)
36. Ali I. U., Schriml L. M., Dean M., Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity Journal of the National Cancer Institute 1999 91 22 1922 1932
37. Bose S., Wang S. I., Terry M. B., Hibshoosh H., Parsons R., Allelic loss of chromosome 10q23 is associated with tumor progression in breast carcinomas Oncogene 1998 17 1 123 127 (Pubitemid 28360536)
38. Feilotter H. E., Coulon V., McVeigh J. L., Boag A. H., Dorion-Bonnet F., Duboué B., Latham W. C. W., Eng C., Mulligan L. M., Longy M., Analysis of the 10q23 chromosomal region and the PTEN gene in human sporadic breast carcinoma British Journal of Cancer 1999 79 5-6 718 723 (Pubitemid 29082095)
39. Waite K. A., Eng C., Protean PTEN: form and function American Journal of Human Genetics 2002 70 4 829 844 (Pubitemid 34259300)
40. Chen Z., Trotman L. C., Shaffer D., Lin H. K., Dotan Z. A., Niki M., Koutcher J. A., Scher H. I., Ludwig T., Gerald W., Cordon-Cardo C., Pandolfi P. P., Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis Nature 2005 436 7051 725 730 (Pubitemid 41117277)
41. Campisi J., d'Adda Di Fagagna F., Cellular senescence: when bad things happen to good cells Nature Reviews Molecular Cell Biology 2007 8 9 729 740 (Pubitemid 47312822)
42. Li D. M., Sun H., TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor Cancer Research 1997 57 11 2124 2129 (Pubitemid 27247025)
43. Virolle T., Adamson E. D., Baron V., Birle D., Mercola D., Mustelin T., De Belle I., The Egr-1 transcription factor directly activates PTEN during irradiation-induced signalling Nature Cell Biology 2001 3 12 1124 1128 (Pubitemid 33130464)
44. Moorehead R. A., Hojilla C. V., De Belle I., Wood G. A., Fata J. E., Adamson E. D., Watson K. L. M., Edwards D. R., Khokha R., Insulin-like growth factor-II regulates PTEN expression in the mammary gland The Journal of Biological Chemistry 2003 278 50 50422 50427 (Pubitemid 37548886)
45. Patel L., Pass I., Coxon P., Downes C. P., Smith S. A., Macphee C. H., Tumor suppressor and anti-inflammatory actions of PPAR agonists are mediated via upregulation of PTEN Current Biology 2001 11 10 764 768 (Pubitemid 32442793)
46. Stambolic V., MacPherson D., Sas D., Lin Y., Snow B., Jang Y., Benchimol S., Mak T. W., Regulation of PTEN transcription by p53 Molecular Cell 2001 8 2 317 325 (Pubitemid 32831549)
47. Palomero T., Sulis M. L., Cortina M., Real P. J., Barnes K., Ciofani M., Caparros E., Buteau J., Brown K., Perkins S. L., Bhagat G., Agarwal A. M., Basso G., Castillo M., Nagase S., Cordon-Cardo C., Parsons R., Ziga-Pflcker J. C., Dominguez M., Ferrando A. A., Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia Nature Medicine 2007 13 10 1203 1210 (Pubitemid 47530629)
48. Hettinger K., Vikhanskaya F., Poh M. K., Lee M. K., de Belle I., Zhang J. T., Reddy S. A. G., Sabapathy K., c-Jun promotes cellular survival by suppression of PTEN Cell Death and Differentiation 2007 14 2 218 229 (Pubitemid 46092225)
49. Xia D., Srinivas H., Ahn Y. H., Sethi G., Sheng X., Yung W. K. A., Xia Q., Chiao P. J., Kim H., Brown P. H., Wistuba I. I., Aggarwal B. B., Kurie J. M., Mitogen-activated protein kinase kinase-4 promotes cell survival by decreasing PTEN expression through an NF B-dependent pathway The Journal of Biological Chemistry 2007 282 6 3507 3519 (Pubitemid 47084470)
50. Chappell W. H., Green T. D., Spengeman J. D., McCubrey J. A., Akula S. M., Bertrand F. E., Increased protein expression of the PTEN tumor suppressor in the presence of constitutively active notch-1 Cell Cycle 2005 4 10 1389 1395 (Pubitemid 41437129)
51. Whelan J. T., Forbes S. L., Bertrand F. E., CBF-1 (RBP-J ) binds to the PTEN promoter and regulates PTEN gene expression Cell Cycle 2007 6 1 80 84 (Pubitemid 46173885)
52. Garca J. M., Silva J., Pea C., Garcia V., Rodriguez R., Cruz M. A., Cantos B., Provencio M., Espaa P., Bonilla F., Promoter methylation of the PTEN gene is a common molecular change in breast cancer Genes Chromosomes and Cancer 2004 41 2 117 124 (Pubitemid 39096737)
53. Goel A., Arnold C. N., Niedzwiecki D., Carethers J. M., Dowell J. M., Wasserman L., Compton C., Mayer R. J., Bertagnolli M. M., Boland C. R., Frequent inactivation of PTEN by promoter hypermethylation in microsatellite instability-high sporadic colorectal cancers Cancer Research 2004 64 9 3014 3021 (Pubitemid 38581399)
54. Kang Y. H., Hye S. L., Woo H. K., Promoter methylation and silencing of PTEN in gastric carcinoma Laboratory Investigation 2002 82 3 285 291 (Pubitemid 34242522)
55. Meng F., Henson R., Lang M., Wehbe H., Maheshwari S., Mendell J. T., Jiang J., Schmittgen T. D., Patel T., Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines Gastroenterology 2006 130 7 2113 2129 (Pubitemid 43816961)
56. Meng F., Henson R., Wehbe-Janek H., Ghoshal K., Jacob S. T., Patel T., MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer Gastroenterology 2007 133 2 647 658 (Pubitemid 47187346)
57. Chan J. A., Krichevsky A. M., Kosik K. S., MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells Cancer Research 2005 65 14 6029 6033 (Pubitemid 40994386)
58. Si M. L., Zhu S., Wu H., Lu Z., Wu F., Mo Y. Y., miR-21-mediated tumor growth Oncogene 2007 26 19 2799 2803 (Pubitemid 46663837)
59. Volinia S., Calin G. A., Liu C. G., Ambs S., Cimmino A., Petrocca F., Visone R., Iorio M., Roldo C., Ferracin M., Prueitt R. L., Yanaihara N., Lanza G., Scarpa A., Vecchione A., Negrini M., Harris C. C., Croce C. M., A microRNA expression signature of human solid tumors defines cancer gene targets Proceedings of the National Academy of Sciences of the United States of America 2006 103 7 2257 2261 (Pubitemid 43271657)
60. Leslie N. R., Downes C. P., PTEN function: how normal cells control it and tumour cells lose it Biochemical Journal 2004 382 1 1 11 (Pubitemid 39141560)
61. Vazquez F., Grossman S. R., Takahashi Y., Rokas M. V., Nakamura N., Sellers W. R., Phosphorylation of the PTEN tail acts as an inhibitory switch by preventing its recruitment into a protein complex The Journal of Biological Chemistry 2001 276 52 48627 48630
62. Okumura K., Mendoza M., Bachoo R. M., DePinho R. A., Cavenee W. K., Furnari F. B., PCAF modulates PTEN activity The Journal of Biological Chemistry 2006 281 36 26562 26568 (Pubitemid 44401865)
63. Lee S. R., Yang K. S., Kwon J., Lee C., Jeong W., Rhee S. G., Reversible inactivation of the tumor suppressor PTEN by H 2 O 2 The Journal of Biological Chemistry 2002 277 23 20336 20342 (Pubitemid 34967328)
64. Nandi D., Tahiliani P., Kumar A., Chandu D., The ubiquitin-proteasome system Journal of Biosciences 2006 31 1 137 155
65. Torres J., Pulido R., The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation The Journal of Biological Chemistry 2001 276 2 993 998 (Pubitemid 32096519)
66. Wu W., Wang X., Zhang W., Reed W., Samet J. M., Whang Y. E., Ghio A. J., Zinc-induced PTEN protein degradation through the proteasome pathway in human airway epithelial cells The Journal of Biological Chemistry 2003 278 30 28258 28263 (Pubitemid 36900027)
67. Tang Y., Eng C., p53 down-regulates phosphatase and tensin homologue deleted on chromosome 10 protein stability partially through caspase-mediated degradation in cells with proteasome dysfunction Cancer Research 2006 66 12 6139 6148
68. Trotman L. C., Wang X., Alimonti A., Chen Z., Teruya-Feldstein J., Yang H., Pavletich N. P., Carver B. S., Cordon-Cardo C., Erdjument-Bromage H., Tempst P., Chi S. G., Kim H. J., Misteli T., Jiang X., Pandolfi P. P., Ubiquitination regulates PTEN nuclear import and tumor suppression Cell 2007 128 1 141 156 (Pubitemid 46048885)
69. Gimm O., Perren A., Weng L. P., Marsh D. J., Jen Jen Yeh, Ziebold U., Gil E., Hinze R., Delbridge L., Lees J. A., Mutter G. L., Robinson B. G., Komminoth P., Dralle H., Eng C., Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors American Journal of Pathology 2000 156 5 1693 1700 (Pubitemid 30646707)
70. Ginn-Pease M. E., Eng C., Increased nuclear phosphatase and tensin homologue deleted on chromosome 10 is associated with G0-G1 in MCF-7 cells Cancer Research 2003 63 2 282 286 (Pubitemid 36152480)
71. Lachyankar M. B., Sultana N., Schonhoff C. M., Mitra P., Poluha W., Lambert S., Quesenberry P. J., Litofsky N. S., Recht L. D., Nabi R., Miller S. J., Ohta S., Neel B. G., Ross A. H., A role for nuclear PTEN in neuronal differentiation Journal of Neuroscience 2000 20 4 1404 1413 (Pubitemid 30220420)
72. Perren A., Komminoth P., Saremaslani P., Matter C., Feurer S., Lees J. A., Heitz P. U., Eng C., Mutation and expression analyses reveal differential subcellular compartmentalization of PTEN in endocrine pancreatic tumors compared to normal islet cells American Journal of Pathology 2000 157 4 1097 1103
73. Tachibana M., Shibakita M., Ohno S., Kinugasa S., Yoshimura H., Ueda S., Fujii T., Rahman M. A., Dhar D. K., Nagasue N., Expression and prognostic significance of PTEN product protein in patients with esophageal squamous cell carcinoma Cancer 2002 94 7 1955 1960 (Pubitemid 34270048)
74. Whiteman D. C., Zhou X. P., Cummings M. C., Pavey S., Hayward N. K., Eng C., Nuclear PTEN expression and clinicopathologic features in a population-based series of primary cutaneous melanoma International Journal of Cancer 2002 99 1 63 67 (Pubitemid 34273199)
75. Zhou X. P., Gimm O., Hampel H., Niemann T., Walker M. J., Eng C., Epigenetic PTEN silencing in malignant melanomas without PTEN mutation American Journal of Pathology 2000 157 4 1123 1128
76. Zhou X. P., Loukola A., Salovaara R., Nystrom-Lahti M., Peltomki P., De la Chapelle A., Aaltonen L. A., Eng C., PTEN mutational spectra, expression levels, and subcellular localization in microsatellite stable and unstable colorectal cancers American Journal of Pathology 2002 161 2 439 447 (Pubitemid 36142153)
77. Tran M. A., Gowda R., Sharma A., Park E. J., Adair J., Kester M., Smith N. B., Robertson G. P., Targeting V600EB-Raf and Akt3 using nanoliposomal-small interfering RNA inhibits cutaneous melanocytic lesion development Cancer Research 2008 68 18 7638 7649
78. Lo R. S., Witte O. N., Transforming growth factor- activation promotes genetic context-dependent invasion of immortalized melanocytes Cancer Research 2008 68 11 4248 4257
79. Yao D., Alexander C. L., Quinn J. A., Chan W. C., Wu H., Greenhalgh D. A., Fos cooperation with PTEN loss elicits keratoacanthoma not carcinoma, owing to p53/p21WAF-induced differentiation triggered by GSK3 inactivation and reduced AKT activity Journal of Cell Science 2008 121 10 1758 1769 (Pubitemid 351911832)
80. Ferran M., Bussaglia E., Lazaro C., Matias-Guiu X., Pujol R. M., Acral papular neuromatosis: an early manifestation of Cowden syndrome British Journal of Dermatology 2008 158 1 174 176 (Pubitemid 350221894)
81. Schaffer J. V., Kamino H., Witkiewicz A., McNiff J. M., Orlow S. J., Mucocutaneous neuromas: an underrecognized manifestation of PTEN hamartoma-tumor syndrome Archives of Dermatology 2006 142 5 625 632 (Pubitemid 43727554)
82. Katona T. M., O'Malley D. P., Cheng L., Hiatt K. M., Wang M., Anagnostou J. J., Billings S. D., Smoller B. R., Loss of heterozygosity analysis identifies genetic abnormalities in mycosis fungoides and specific loci associated with disease progression American Journal of Surgical Pathology 2007 31 10 1552 1556 (Pubitemid 47482469)
83. Kim N. H., Jeon S., Lee H. J., Lee A. Y., Impaired PI3K/Akt activation-mediated NF- B inactivation under elevated TNF- is more vulnerable to apoptosis in vitiliginous keratinocytes Journal of Investigative Dermatology 2007 127 11 2612 2617 (Pubitemid 47585062)
84. Eng C., PTEN: one gene, Many syndromes Human Mutation 2003 22 3 183 198 (Pubitemid 37071635)
85. Romano C., Ruggieri M., Pascual Castroviejo I., Di Rocco C., Genetics of PTEN hamatoma tumor syndrome (PHTS) Neurocutaneous Disorders. Phakomatoses and Hamartoneoplastis Syndromes 2008 Springer
86. Hildenbrand C., Burgdorf W. H. C., Lautenschlager S., Cowden syndromediagnostic skin signs Dermatology 2001 202 4 362 366
87. Hendriks Y. M. C., Verhallen J. T. C. M., Van der Smagt J. J., Kant S. G., Hilhorst Y., Hoefsloot L., Hansson K. B. M., Van der Straaten P. J. C., Boutkan H., Breuning M. H., Vasen H. F. A., Brcker-Vriends A. H. J. T., Bannayan-Riley-Ruvalcaba syndrome: further delineation of the phenotype and management of PTEN mutation-positive cases Familial Cancer 2003 2 2 79 85 (Pubitemid 37247979)
88. Satter E., Proteus syndrome: 2 Case reports and a review or the literature Cutis 2007 80 4 297 302
89. Schepis C., Greco D., Siragusa M., Romano C., Cerebriform plantar hyperplasia: The major cutaneous feature of Proteus syndrome International Journal of Dermatology 2008 47 4 374 376 (Pubitemid 351486482)